{"id":"NCT00969709","sponsor":"Forest Laboratories","briefTitle":"Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder","officialTitle":"A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-09","primaryCompletion":"2011-05","completion":null,"firstPosted":"2009-09-01","resultsPosted":"2013-10-25","lastUpdate":"2013-10-25"},"enrollment":724,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Major Depressive Disorder"],"interventions":[{"type":"DRUG","name":"Levomilnacipran ER","otherNames":[]},{"type":"DRUG","name":"Levomilnacipran ER","otherNames":[]},{"type":"DRUG","name":"Levomilnacipran ER","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"EXPERIMENTAL"},{"label":"3","type":"EXPERIMENTAL"},{"label":"4","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy, safety, and tolerability of Levomilnacipran ER fixed doses versus placebo in the treatment of outpatients with major depressive disorder.","primaryOutcome":{"measure":"Change in Montgomery-Ã…sberg Depression Rating Scale (MADRS) Total Score","timeFrame":"From Baseline to Week 8","effectByArm":[{"arm":"Placebo","deltaMin":-11.6,"sd":0.97},{"arm":"Levomilnacipran ER 40 mg","deltaMin":-14.8,"sd":0.99},{"arm":"Levomilnacipran ER 80 mg","deltaMin":-15.6,"sd":1},{"arm":"Levomilnacipran ER 120 mg","deltaMin":-16.5,"sd":1.02}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0186"},{"comp":"OG000 vs OG002","p":"0.0038"},{"comp":"OG000 vs OG003","p":"0.0005"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":38,"countries":["United States"]},"refs":{"pmids":["26644957","25259674","23561229"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":176},"commonTop":["Headache","Nausea","Dry mouth","Constipation","Heart rate increased"]}}